Clinical Trial Update: A Single-Arm Phase Ⅱ Study of Fluzoparib Maintenance in Platinum-sensitive Advanced Triple-Negative Breast Cance [Phase 2]

View source ↗

Summary

A single-arm Phase II trial evaluating maintenance therapy with Fluzoparib in platinum-sensitive advanced triple-negative breast cancer. The study includes pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Fluzoparib (fluzoparib)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Platinum-sensitive, TNBC, Triple Negative Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING